Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100422184C details a telescoped synthesis for Meropenem, improving yield and reducing solvent use for reliable pharmaceutical intermediate supply.
Patent CN1384105A details a robust asymmetric copper complex for cyclopropanation, offering significant cost reduction in agrochemical intermediate manufacturing and enhanced supply chain reliability.
Patent CN120718880B reveals high-efficiency transaminase mutant for Cinacalcet intermediate synthesis offering significant cost and supply chain advantages.
Patent CN114507650A details a high-efficiency biocatalytic route for Clopidogrel intermediates, offering superior stereoselectivity and substrate tolerance for scalable API manufacturing.
Patent CN108486075A details a mutant enzyme for statin side chains, offering enhanced catalytic efficiency and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN118480524B details mutant enzyme synthesis for chloramphenicol intermediates. Delivers high yield and green manufacturing advantages for reliable pharmaceutical intermediates supplier partnerships.
Patent CN114277073A reveals gene-knockout method for high-purity SAM. Reduces purification costs and ensures supply chain stability for pharmaceutical intermediates.
Patent CN105753703B enables eco-friendly asymmetric hydroxylation using molecular oxygen. Delivers high purity intermediates with reduced environmental impact for global supply chains.
Patent CN116179503A details a novel recombinant aminotransferase route for Niraparib intermediates, offering high stereoselectivity and eliminating costly chiral chromatography for supply chain efficiency.
Patent CN1101817C reveals a cost-effective route to tetraazamacrocycles using dichloroethane and halide catalysts, offering significant supply chain advantages for MRI contrast agent precursors.
Patent CN115851685A reveals a breakthrough nitrilase mutant for efficient 3-hydroxy-3-methylbutyric acid production, offering significant cost reduction and green manufacturing advantages.
Patent CN104561142A reveals nitrilase biosynthesis for statin intermediates. Offers mild conditions, high yield, and supply chain stability for global pharmaceutical manufacturing.
Patent CN114150009A reveals a novel enzymatic route for ephedrine using engineered E. coli and yeast, offering high yield and environmental compliance for pharma supply chains.
Patent CN114958934A reveals a novel glutamate dehydrogenase method for L-glufosinate. Achieve high purity and cost reduction in agrochemical intermediate manufacturing.
High-yield imine reductase method for ephedrine production offers supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN107686457A details ferrous salt catalysis for high-purity pharmaceutical intermediates. Discover cost reduction and supply chain advantages.
Patent CN110951706B details a high-activity R-omega-TA mutant for sitagliptin. Offers high ee value >99%, breaking technical monopolies and ensuring supply chain stability.
Patent CN112724003B reveals a safer, high-yield route for 9-fluorenylformaldehyde using mixed alkoxides, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101429192A details a novel chiral titanium catalysis method for high-purity proton pump inhibitor intermediates, offering significant supply chain and cost advantages.
Patent CN110577941A reveals mutated amine dehydrogenase for asymmetric reductive amination. Enables cost reduction in pharmaceutical intermediates manufacturing with high optical purity.